{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:09:48Z","timestamp":1778695788135,"version":"3.51.4"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,3,14]],"date-time":"2014-03-14T00:00:00Z","timestamp":1394755200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1038\/npp.2014.65","type":"journal-article","created":{"date-parts":[[2014,3,14]],"date-time":"2014-03-14T17:15:45Z","timestamp":1394817345000},"page":"2170-2178","source":"Crossref","is-referenced-by-count":27,"title":["Identification of Candidate Single-Nucleotide Polymorphisms in NRXN1 Related to Antipsychotic Treatment Response in Patients with Schizophrenia"],"prefix":"10.1038","volume":"39","author":[{"given":"Aaron","family":"Jenkins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A","family":"Apud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Decot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel R","family":"Weinberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda J","family":"Law","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,14]]},"reference":[{"key":"BFnpp201465_CR1","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1176\/appi.ajp.2012.11081214","volume":"169","author":"JA Apud","year":"2012","unstructured":"Apud JA, Zhang F, Decot H, Bigos KL, Weinberger DR (2012). Genetic variation in KCNH2 associated with expression in the brain of a unique hERG isoform modulates treatment response in patients with schizophrenia. Am J Psychiatry 169: 725\u2013734.","journal-title":"Am J Psychiatry"},{"key":"BFnpp201465_CR2","doi-asserted-by":"publisher","first-page":"4045","DOI":"10.1093\/hmg\/ddn307","volume":"17","author":"AS Bassett","year":"2008","unstructured":"Bassett AS, Marshall CR, Lionel AC, Chow EW, Scherer SW (2008). Copy number variations and risk for schizophrenia in 22q11.2 deletion syndrome. Hum Mol Genet 17: 4045\u20134053.","journal-title":"Hum Mol Genet"},{"key":"BFnpp201465_CR3","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/ajmg.b.32148","volume":"162B","author":"F Bena","year":"2013","unstructured":"Bena F, Bruno DL, Eriksson M, van Ravenswaaij-Arts C, Stark Z, Dijkhuizen T et al (2013). Molecular and clinical characterization of 25 individuals with exonic deletions of NRXN1 and comprehensive review of the literature. Am J Med Genet B Neuropsychiatr Genet 162B: 388\u2013403.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"BFnpp201465_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/hmg\/ddl441","volume":"16","author":"LJ Bierut","year":"2007","unstructured":"Bierut LJ, Madden PA, Breslau N, Johnson EO, Hatsukami D, Pomerleau OF et al (2007). Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum Mol Genet 16: 24\u201335.","journal-title":"Hum Mol Genet"},{"key":"BFnpp201465_CR5","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/mp.2011.38","volume":"16","author":"KL1 Bigos","year":"2011","unstructured":"Bigos KL1, Bies RR, Pollock BG, Lowy JJ, Zhang F, Weinberger DR (2011). Genetic variation in CYP3A43 explains racial difference in olanzapine clearance. Mol Psychiatry 16: 620\u2013625.","journal-title":"Mol Psychiatry"},{"key":"BFnpp201465_CR6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1177\/0091270007310385","volume":"48","author":"KL1 Bigos","year":"2008","unstructured":"Bigos KL1, Pollock BG, Coley KC, Miller DD, Marder SR, Aravagiri M et al (2008). Sex, race, and smoking impact olanzapine exposure. J Clin Pharmacol 48: 157\u2013165.","journal-title":"J Clin Pharmacol"},{"key":"BFnpp201465_CR7","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.ajhg.2013.02.006","volume":"92","author":"X Chen","year":"2013","unstructured":"Chen X, Shen Y, Zhang F, Chiang C, Pillalamarri V, Blumenthal I et al (2013). Molecular analysis of a deletion hotspot in the NRXN1 region reveals the involvement of short inverted repeats in deletion CNVs. Am J Hum Genet 92: 375\u2013386.","journal-title":"Am J Hum Genet"},{"key":"BFnpp201465_CR8","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1002\/ajmg.a.35780","volume":"161","author":"MP Dabell","year":"2013","unstructured":"Dabell MP, Rosenfeld JA, Bader P, Escobar LF, El-Khechen D, Vallee SE et al (2013). Investigation of NRXN1 deletions: clinical and molecular characterization. Am J Med Genet 161: 717\u2013731.","journal-title":"Am J Med Genet"},{"key":"BFnpp201465_CR9","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/j.1601-183X.2012.00815.x","volume":"11","author":"E Docampo","year":"2012","unstructured":"Docampo E, Ribases M, Gratacos M, Bruguera E, Cabezas C, Sanchez-Mora C et al (2012). Association of neurexin 3 polymorphisms with smoking behavior. Genes Brain Behav 11: 704\u2013711.","journal-title":"Genes Brain Behav"},{"key":"BFnpp201465_CR10","doi-asserted-by":"publisher","first-page":"10599","DOI":"10.1523\/JNEUROSCI.1913-06.2006","volume":"26","author":"I Dudanova","year":"2006","unstructured":"Dudanova I, Sedej S, Ahmad M, Masius H, Sargsyan V, Zhang W et al (2006). Important contribution of alpha-neurexins to Ca2+-triggered exocytosis of secretory granules. J Neurosci 26: 10599\u201310613.","journal-title":"J Neurosci"},{"key":"BFnpp201465_CR11","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/ajmg.b.32036","volume":"159B","author":"L Duong","year":"2012","unstructured":"Duong L, Klitten LL, Moller RS, Ingason A, Jakobsen KD, Skjodt C et al (2012). Mutations in NRXN1 in a family multiply affected with brain disorders: NRXN1 mutations and brain disorders. Am J Med Genet B Neuropsychiatr Genet 159B: 354\u2013358.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"BFnpp201465_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1023\/A:1024145407467","volume":"118","author":"L Fedorova","year":"2003","unstructured":"Fedorova L, Fedorov A (2003). Introns in gene evolution. Genetica 118: 123\u2013131.","journal-title":"Genetica"},{"key":"BFnpp201465_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00406-012-0348-1","volume":"263","author":"I Giegling","year":"2013","unstructured":"Giegling I, Balzarro B, Porcelli S, Schafer M, Hartmann AM, Friedl M et al (2013). Influence of ANKK1 and DRD2 polymorphisms in response to haloperidol. Eur Arch Psychiatry Clin Neurosci 263: 65\u201374.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"BFnpp201465_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.pneurobio.2012.07.005","volume":"99","author":"HM Grayton","year":"2012","unstructured":"Grayton HM, Fernandes C, Rujescu D, Collier DA (2012). Copy number variations in neurodevelopmental disorders. Prog Neurobiol 99: 81\u201391.","journal-title":"Prog Neurobiol"},{"key":"BFnpp201465_CR15","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1093\/hmg\/ddm247","volume":"16","author":"A Hishimoto","year":"2007","unstructured":"Hishimoto A, Liu QR, Drgon T, Pletnikova O, Walther D, Zhu XG et al (2007). Neurexin 3 polymorphisms are associated with alcohol dependence and altered expression of specific isoforms. Hum Mol Genet 16: 2880\u20132891.","journal-title":"Hum Mol Genet"},{"key":"BFnpp201465_CR16","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.2217\/14622416.9.10.1437","volume":"9","author":"M Ikeda","year":"2008","unstructured":"Ikeda M, Yamanouchi Y, Kinoshita Y, Kitajima T, Yoshimura R, Hashimoto S et al (2008). Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia. Pharmacogenomics 9: 1437\u20131443.","journal-title":"Pharmacogenomics"},{"key":"BFnpp201465_CR17","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.biopsych.2009.08.034","volume":"67","author":"M Ikeda","year":"2010","unstructured":"Ikeda M, Aleksic B, Kirov G, Kinoshita Y, Yamanouchi Y, Kitajima T et al (2010). Copy number variation in schizophrenia in the Japanese population. Biol Psychiatry 67: 283\u2013286.","journal-title":"Biol Psychiatry"},{"key":"BFnpp201465_CR18","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature07239","volume":"455","author":"International Schizophrenia Consortium","year":"2008","unstructured":"International Schizophrenia Consortium (2008). Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455: 237\u2013241.","journal-title":"Nature"},{"key":"BFnpp201465_CR19","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.pnpbp.2003.09.004","volume":"27","author":"S Kapur","year":"2003","unstructured":"Kapur S, Mamo D (2003). Half a century of antipsychotics and still a central role for dopamine D2 receptors. Prog Neuropsychopharmacol Biol Psychiatry 27: 1081\u20131090.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFnpp201465_CR20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/0010-440X(91)90085-Q","volume":"32","author":"SR Kay","year":"1991","unstructured":"Kay SR, Opler LA, Spitzer RL, Williams JB, Fiszbein A, Gorelick A (1991). SCID-PANSS: two-tier diagnostic system for psychotic disorders. Compr Psychiatry 32: 355\u2013361.","journal-title":"Compr Psychiatry"},{"key":"BFnpp201465_CR21","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1093\/hmg\/ddm323","volume":"17","author":"G Kirov","year":"2008","unstructured":"Kirov G, Gumus D, Chen W, Norton N, Georgieva L, Sari M et al (2008). Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia. Hum Mol Genet 17: 458\u2013465.","journal-title":"Hum Mol Genet"},{"key":"BFnpp201465_CR22","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/schbul\/sbp079","volume":"35","author":"G Kirov","year":"2009","unstructured":"Kirov G, Rujescu D, Ingason A, Collier DA, O'Donovan MC, Owen MJ (2009). Neurexin 1 (NRXN1) deletions in schizophrenia. Schizophr Bull 35: 851\u2013854.","journal-title":"Schizophr Bull"},{"key":"BFnpp201465_CR23","doi-asserted-by":"publisher","first-page":"12165","DOI":"10.1073\/pnas.1206118109","volume":"109","author":"AJ Law","year":"2012","unstructured":"Law AJ, Wang Y, Sei Y, O'Donnell P, Piantadosi P, Papaleo F et al (2012). Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110delta inhibition as a potential therapeutic strategy. Proc Natl Acad Sci USA 109: 12165\u201312170.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp201465_CR24","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.schres.2011.08.007","volume":"132","author":"TA Lett","year":"2011","unstructured":"Lett TA, Tiwari AK, Meltzer HY, Lieberman JA, Potkin SG, Voineskos AN et al (2011). The putative functional rs1045881 marker of neurexin-1 in schizophrenia and clozapine response. Schizophr Res 132: 121\u2013124.","journal-title":"Schizophr Res"},{"key":"BFnpp201465_CR25","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1056\/NEJMoa051688","volume":"353","author":"JA Lieberman","year":"2005","unstructured":"Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO et al (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353: 1209\u20131223.","journal-title":"N Engl J Med"},{"key":"BFnpp201465_CR26","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1176\/appi.ajp.2012.12040457","volume":"169","author":"FE Lotrich","year":"2012","unstructured":"Lotrich FE (2012). The emerging potential of pharmacogenetics in psychiatry. Am J Psychiatry 169: 681\u2013683.","journal-title":"Am J Psychiatry"},{"key":"BFnpp201465_CR27","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/mp.2011.146","volume":"17","author":"AK Malhotra","year":"2012","unstructured":"Malhotra AK, Zhang JP, Lencz T (2012a). Pharmacogenetics in psychiatry: translating research into clinical practice. Mol Psychiatry 17: 760\u2013769.","journal-title":"Mol Psychiatry"},{"key":"BFnpp201465_CR28","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1001\/archgenpsychiatry.2012.191","volume":"69","author":"AK Malhotra","year":"2012","unstructured":"Malhotra AK, Correll CU, Chowdhury NI, M\u00fcller DJ, Gregersen PK, Lee AT et al (2012b). Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain. Arch Gen Psychiatry 69: 904\u2013912.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp201465_CR29","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1046\/j.1471-4159.1998.71041339.x","volume":"71","author":"M Missler","year":"1998","unstructured":"Missler M, Fernandez-Chacon R, Sudhof TC (1998). The making of neurexins. J Neurochem 71: 1339\u20131347.","journal-title":"J Neurochem"},{"key":"BFnpp201465_CR30","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/nature01755","volume":"423","author":"M Missler","year":"2003","unstructured":"Missler M, Zhang W, Rohlmann A, Kattenstroth G, Hammer RE, Gottmann K et al (2003). Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. Nature 423: 939\u2013948.","journal-title":"Nature"},{"key":"BFnpp201465_CR31","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/epi.12078","volume":"54","author":"RS Moller","year":"2013","unstructured":"Moller RS, Weber YG, Klitten LL, Trucks H, Muhle H, Kunz WS et al (2013). Exon-disrupting deletions of NRXN1 in idiopathic generalized epilepsy. Epilepsia 54: 256\u2013264.","journal-title":"Epilepsia"},{"key":"BFnpp201465_CR32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.schres.2011.01.001","volume":"127","author":"TW Muhleisen","year":"2011","unstructured":"Muhleisen TW, Basmanav FB, Forstner AJ, Mattheisen M, Priebe L, Herms S et al (2011). Resequencing and follow-up of neurexin 1 (NRXN1) in schizophrenia patients. Schizophr Res 127: 35\u201340.","journal-title":"Schizophr Res"},{"key":"BFnpp201465_CR33","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1038\/ejhg.2008.264","volume":"17","author":"AC Need","year":"2009","unstructured":"Need AC, Keefe RS, Ge D, Grossman I, Dickson S, McEvoy JP et al (2009). Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. Eur J Hum Genet 17: 946\u2013957.","journal-title":"Eur J Hum Genet"},{"key":"BFnpp201465_CR34","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1093\/hmg\/ddn044","volume":"17","author":"J Nussbaum","year":"2008","unstructured":"Nussbaum J, Xu Q, Payne TJ, Ma JZ, Huang W, Gelernter J et al (2008). Significant association of the neurexin-1 gene (NRXN1) with nicotine dependence in European- and African-American smokers. Hum Mol Genet 17: 1569\u20131577.","journal-title":"Hum Mol Genet"},{"key":"BFnpp201465_CR35","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/schbul\/sbs103","volume":"38","author":"MJ Owen","year":"2012","unstructured":"Owen MJ (2012). Implications of genetic findings for understanding schizophrenia. Schizophr Bull 38: 904\u2013907.","journal-title":"Schizophr Bull"},{"key":"BFnpp201465_CR36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/bmb\/ldh055","volume":"73-74","author":"S Prathikanti","year":"2005","unstructured":"Prathikanti S, Weinberger DR (2005). Psychiatric genetics\u2014the new era: genetic research and some clinical implications. Br Med Bull 73-74: 107\u2013122.","journal-title":"Br Med Bull"},{"key":"BFnpp201465_CR37","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1038\/ng.2742","volume":"45","author":"Ripke","year":"2013","unstructured":"Ripke, Chambert K, Moran JL, K\u00e4hler AK, Akterin S, Bergen SE et al (2013). Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet 45: 1150\u20131159.","journal-title":"Nat Genet"},{"key":"BFnpp201465_CR38","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1006\/geno.2002.6734","volume":"79","author":"L Rowen","year":"2002","unstructured":"Rowen L, Young J, Birditt B, Kaur A, Madan A, Philipps DL et al (2002). Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. Genomics 79: 587\u2013597.","journal-title":"Genomics"},{"key":"BFnpp201465_CR39","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1093\/hmg\/ddn351","volume":"18","author":"D Rujescu","year":"2009","unstructured":"Rujescu D, Ingason A, Cichon S, Pietilainen OP, Barnes MR, Toulopoulou T et al (2009). Disruption of the neurexin 1 gene is associated with schizophrenia. Hum Mol Genet 18: 988\u2013996.","journal-title":"Hum Mol Genet"},{"key":"BFnpp201465_CR40","doi-asserted-by":"publisher","first-page":"e7853","DOI":"10.1371\/journal.pone.0007853","volume":"4","author":"S Shepard","year":"2009","unstructured":"Shepard S, McCreary M, Fedorov A (2009). The peculiarities of large intron splicing in animals. PLoS One 4: e7853.","journal-title":"PLoS One"},{"key":"BFnpp201465_CR41","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1176\/ajp.138.7.992","volume":"138","author":"SH Snyder","year":"1981","unstructured":"Snyder SH (1981). Dopamine receptors, neuroleptics, and schizophrenia. Am J Psychiatry 138: 460\u2013464.","journal-title":"Am J Psychiatry"},{"key":"BFnpp201465_CR42","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00213-008-1193-9","volume":"200","author":"RP Souza","year":"2008","unstructured":"Souza RP, Romano-Silva MA, Lieberman JA, Meltzer HY, Wong AH, Kennedy JL (2008). Association study of GSK3 gene polymorphisms with schizophrenia and clozapine response. Psychopharmacology (Berl) 200: 177\u2013186.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp201465_CR43","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/hup.1146","volume":"25","author":"RP Souza","year":"2010","unstructured":"Souza RP, Meltzer HY, Lieberman JA, Le FB, Kennedy JL (2010). Influence of neurexin 1 (NRXN1) polymorphisms in clozapine response. Hum Psychopharmacol 25: 582\u2013585.","journal-title":"Hum Psychopharmacol"},{"key":"BFnpp201465_CR44","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nature07229","volume":"455","author":"H Stefansson","year":"2008","unstructured":"Stefansson H, Rujescu D, Cichon S, Pietilainen OP, Ingason A, Steinberg S et al (2008). Large recurrent microdeletions associated with schizophrenia. Nature 455: 232\u2013236.","journal-title":"Nature"},{"key":"BFnpp201465_CR45","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/nature07456","volume":"455","author":"TC Sudhof","year":"2008","unstructured":"Sudhof TC (2008). Neuroligins and neurexins link synaptic function to cognitive disease. Nature 455: 903\u2013911.","journal-title":"Nature"},{"key":"BFnpp201465_CR46","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrg3240","volume":"13","author":"PF Sullivan","year":"2012","unstructured":"Sullivan PF, Daly MJ, O'Donovan M (2012). Genetic architectures of psychiatric disorders: the emerging picture and its implications. Nat Rev Genet 13: 537\u2013551.","journal-title":"Nat Rev Genet"},{"key":"BFnpp201465_CR47","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/mp.2008.74","volume":"14","author":"PF Sullivan","year":"2008","unstructured":"Sullivan PF, Lin D, Tzeng JY, van den Oord E, Perkins D, Stroup TS et al (2008). Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol Psychiatry 14: 1144\u20131144.","journal-title":"Mol Psychiatry"},{"key":"BFnpp201465_CR48","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2174\/156720512802455331","volume":"9","author":"S Swaminathan","year":"2012","unstructured":"Swaminathan S, Shen L, Kim S, Inlow M, West JD, Faber KM et al (2012). Analysis of copy number variation in Alzheimer's disease: the NIALOAD\/ NCRAD Family Study. Curr Alzheimer Res 9: 801\u2013814.","journal-title":"Curr Alzheimer Res"},{"key":"BFnpp201465_CR49","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.neuron.2006.09.003","volume":"51","author":"F Varoqueaux","year":"2006","unstructured":"Varoqueaux F, Aramuni G, Rawson RL, Mohrmann R, Missler M, Gottmann K et al (2006). Neuroligins determine synapse maturation and function. Neuron 51: 741\u2013754.","journal-title":"Neuron"},{"key":"BFnpp201465_CR50","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1001\/archpsyc.1987.01800190080012","volume":"44","author":"DR Weinberger","year":"1987","unstructured":"Weinberger DR (1987). Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44: 660\u2013669.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp201465_CR51","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.neuron.2010.04.008","volume":"66","author":"C Zhang","year":"2010","unstructured":"Zhang C, Atasoy D, Arac D, Yang X, Fucillo MV, Robison AJ et al (2010). Neurexins physically and functionally interact with GABA(A) receptors. Neuron 66: 403\u2013416.","journal-title":"Neuron"},{"key":"BFnpp201465_CR52","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1176\/appi.ajp.2009.09040598","volume":"167","author":"JP Zhang","year":"2010","unstructured":"Zhang JP, Lencz T, Malhotra AK (2010). D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis. Am J Psychiatry 167: 763\u2013772.","journal-title":"Am J Psychiatry"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp201465.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201465","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp201465.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:49:39Z","timestamp":1716598179000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp201465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,14]]},"references-count":52,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["BFnpp201465"],"URL":"https:\/\/doi.org\/10.1038\/npp.2014.65","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,14]]}}}